Home › Therapeutic areas › Metabolic › MASH

MASH (7 companies)

Companies with an active program in MASH.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ALT Altimmune GI/HepatologyMetabolic+1 1 Phase 3 $298M 3
BLTE Belite Bio MetabolicOphthalmology Rare 2 NDA Submitted $6.35B 6
CMMB Chemomab Therapeutics GI/HepatologyImmunology+1 Rare 1 Phase 2 $13.2M 4
PRQR ProQR Therapeutics MetabolicNeurology Rare 1 Phase 1 $163M 7
SGMT Sagimet Biosciences DermatologyMetabolic 1 Phase 3 $709M 3
VKTX Viking Therapeutics MetabolicNeurology Rare 1 Phase 3 $3.43B 9
WVE Wave Life Sciences MetabolicNeurology+1 Rare 1 Phase 2 $560M 5